Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab for biliary atresia in infants
ChiCTR2000031738Phase 4Recruiting
- Sponsor
- Guangzhou Women and Children Medical Center
- Start
- Feb 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of rituximab in biliary atresia (2 arms), sponsored by Guangzhou Women and Children Medical Center. Primary endpoints: Liver function index, Lymphocyte count and 1 more. Started Feb 2020; status: recruiting.
02
Drugs
rituximab
03
Conditions
biliary atresia
Beyond the preview
Go deeper on ChiCTR2000031738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000031738.